ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
亚盛医药
32.71
-1.5900
-4.64%
盘后:
32.71
0.0000
0.00%
16:10 EST
成交量:
1,851.00
成交额:
6.13万
市值:
30.53亿
市盈率:
-16.52
高:
32.71
开:
32.71
低:
32.71
收:
34.30
52周最高:
48.45
52周最低:
16.50
股本:
9,333.04万
流通股本:
7,158.28万
量比:
0.28
换手率:
0.00%
股息:
- -
股息率:
- -
每股收益(TTM):
-1.9795
每股收益(LYR):
-0.7356
净资产收益率:
-159.65%
总资产收益率:
-22.77%
市净率:
32.61
市盈率(LYR):
-44.47
数据加载中...
总览
公司
新闻资讯
公告
每日卖空追踪 | 亚盛医药-B 08月19日卖空量成交10.09万股,卖空比例为2.48%
市场透视
·
08/19
亚盛医药-B08月19日遭主力抛售1755.3万元
市场透视
·
08/19
每日卖空追踪 | 亚盛医药-B 08月18日卖空量成交28.74万股,卖空比例为3.94%
市场透视
·
08/18
冲击四连涨!港股创新药精选ETF(520690)净值创上市新高,资金净流入额6268万元
格隆汇
·
08/18
“港股科技双雄”同步走强!港股通创新药ETF(520880)涨逾2%,亚盛医药飙升9%创新高
新浪基金
·
08/18
港股异动 | 亚盛医药-B(06855)高开逾4% 利生妥治疗中高危MDS III期临床研究获美国FDA和欧洲EMA批准
智通财经
·
08/18
部分中概股夜盘上扬爱奇艺、亚盛医药涨近5%小牛电动涨超4%哔哩哔哩涨超2%。
智通财经
·
08/18
亚盛医药-B(06855):利生妥®一线治疗中高危MDS患者的全球注册III期临床研究获美国FDA和欧洲EMA批准
智通财经
·
08/18
亚盛医药-B08月13日获主力加仓1320.6万元
市场透视
·
08/13
亚盛医药8月11日成交额为9.30万美元
市场透视
·
08/12
亚盛医药-B:董事会会议通告
香港交易所
·
08/08
小摩:升亚盛医药目标价至93港元 评级“增持”
新浪港股
·
08/08
小摩:升亚盛医药(06855.HK)目标价至93港元 评级“增持”
智通财经
·
08/08
亚盛医药8月7日成交额为13.12万美元
市场透视
·
08/08
亚盛医药上涨2.38%,报43.0美元/股,总市值39.97亿美元
金融界
·
08/07
亚盛医药8月4日成交额为10.83万美元
市场透视
·
08/05
亚盛医药8月1日成交额为35.92万美元
市场透视
·
08/02
亚盛医药7月30日成交额为28.97万美元
市场透视
·
07/31
亚盛医药上涨2.29%,报40.168美元/股,总市值37.34亿美元
金融界
·
07/30
国内首款Bcl-2抑制剂利生妥®在京东健康全网首发 助力血液肿瘤精准治疗
砍柴网
·
07/29
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/AAPG/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AAPG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAPG\",,,,,undefined,":{"symbol":"AAPG","market":"US","secType":"STK","nameCN":"亚盛医药","latestPrice":32.71,"timestamp":1763413200000,"preClose":34.3,"halted":0,"volume":1851,"hourTrading":{"tag":"盘后","latestPrice":32.71,"preClose":32.71,"latestTime":"16:10 EST","volume":2,"amount":65.42,"timestamp":1763413804114},"delay":0,"floatShares":71582800,"shares":93330405,"eps":-1.979486,"marketStatus":"未开盘","change":-1.59,"latestTime":"11-17 16:00:00 EST","open":32.71,"high":32.71,"low":32.71,"amount":61259.7596,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.979486,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1763456400000},"marketStatusCode":0,"adr":0,"adrRate":4,"listingDate":1737694800000,"exchange":"NASDAQ","adjPreClose":34.3,"preHourTrading":{"tag":"盘前","latestPrice":34,"preClose":34.3,"latestTime":"08:27 EST","volume":200,"amount":6800,"timestamp":1763386049775},"postHourTrading":{"tag":"盘后","latestPrice":32.71,"preClose":32.71,"latestTime":"16:10 EST","volume":2,"amount":65.42,"timestamp":1763413804114},"volumeRatio":0.276475},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAPG\",,,,,undefined,":{"symbol":"AAPG","floatShares":71582800,"roa":"-22.77%","roe":"-159.65%","lyrEps":-0.735552,"volumeRatio":0.276475,"shares":93330405,"dividePrice":0,"high":32.71,"amplitude":0,"preClose":34.3,"low":32.71,"week52Low":16.5,"pbRate":"32.61","psRate":"55.61","week52High":48.45,"institutionHeld":0,"latestPrice":32.71,"eps":-1.979486,"divideRate":0,"volume":1851,"delay":0,"ttmEps":-1.979486,"open":32.71,"prevYearClose":17.25,"prevWeekClose":34.3,"prevMonthClose":33.42,"prevQuarterClose":39.04,"fiveDayClose":32.4,"twentyDayClose":35.31,"sixtyDayClose":47.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AAPG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-20","symbol":"AAPG","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1755662400000,"reportTimeType":"post","actualEps":null},{"date":"2025-03-27","symbol":"AAPG","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":null,"defaultRemindTime":1743062400000,"name":null,"time":"盘前","dateTimestamp":1743048000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AAPG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AAPG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1762837200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AAPG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AAPG","date":"2025-11-14","current":-16.524492,"percent":0.930693,"low":-76.454813,"twenty":-55.920234,"median":-33.485756,"eighty":-22.342071,"high":-18.112503,"avg":-37.21958,"sd":15.491716,"marketCap":3199584585.23},"quantilePoints":[{"date":"2025-01-31","current":-29.751262,"twenty":-29.75286,"median":-29.751983,"eighty":-29.751262,"marketCap":1478269659.08},{"date":"2025-02-07","current":-32.664532,"twenty":-32.365221,"median":-31.242401,"eighty":-29.752127,"marketCap":1614694688.16},{"date":"2025-02-14","current":-31.1828,"twenty":-32.258438,"median":-31.212601,"eighty":-29.752938,"marketCap":1540476496.81},{"date":"2025-02-21","current":-36.382297,"twenty":-32.721933,"median":-31.802125,"eighty":-29.819279,"marketCap":1806628873.73},{"date":"2025-02-28","current":-33.43308,"twenty":-34.468465,"median":-32.375664,"eighty":-30.230932,"marketCap":1654638501.56},{"date":"2025-03-07","current":-34.452224,"twenty":-34.328072,"median":-32.712367,"eighty":-30.892818,"marketCap":1712841480.27},{"date":"2025-03-14","current":-33.065652,"twenty":-34.096417,"median":-32.760201,"eighty":-31.20664,"marketCap":1644428002.08},{"date":"2025-03-21","current":-32.72391,"twenty":-34.124503,"median":-32.947597,"eighty":-31.448698,"marketCap":1626713850.02},{"date":"2025-03-28","current":-33.955809,"twenty":-34.124503,"median":-33.010704,"eighty":-31.793328,"marketCap":1894714451.86},{"date":"2025-04-04","current":-35.921968,"twenty":-34.855052,"median":-33.21342,"eighty":-31.979778,"marketCap":2000185586.04},{"date":"2025-04-11","current":-29.511221,"twenty":-34.370118,"median":-33.010704,"eighty":-30.892818,"marketCap":1635879540.94},{"date":"2025-04-17","current":-29.520055,"twenty":-34.225935,"median":-32.760201,"eighty":-30.07059,"marketCap":1639709582.7},{"date":"2025-04-25","current":-41.553435,"twenty":-35.045268,"median":-32.920123,"eighty":-30.119556,"marketCap":2311372741.24},{"date":"2025-05-02","current":-38.492689,"twenty":-35.554336,"median":-33.187028,"eighty":-30.682879,"marketCap":2146245101.28},{"date":"2025-05-09","current":-37.35919,"twenty":-36.170996,"median":-33.361942,"eighty":-30.776099,"marketCap":2093177176.92},{"date":"2025-05-16","current":-35.007117,"twenty":-35.955639,"median":-33.43308,"eighty":-31.102567,"marketCap":1969122395.28},{"date":"2025-05-23","current":-39.338512,"twenty":-36.352488,"median":-33.608398,"eighty":-31.19472,"marketCap":2213435510.22},{"date":"2025-05-30","current":-38.856398,"twenty":-37.35919,"median":-33.992043,"eighty":-31.242401,"marketCap":2192363417.29},{"date":"2025-06-06","current":-42.814884,"twenty":-37.865895,"median":-34.141844,"eighty":-31.758144,"marketCap":2419987007.19},{"date":"2025-06-13","current":-48.171029,"twenty":-38.492689,"median":-34.477812,"eighty":-31.846105,"marketCap":2722575737.57},{"date":"2025-06-20","current":-55.929302,"twenty":-38.862859,"median":-34.635358,"eighty":-32.113451,"marketCap":3154688383.5},{"date":"2025-06-27","current":-59.787237,"twenty":-39.399619,"median":-35.123604,"eighty":-32.336589,"marketCap":3381751544.24},{"date":"2025-07-03","current":-64.068526,"twenty":-41.436089,"median":-35.258863,"eighty":-32.429915,"marketCap":3624015684.35},{"date":"2025-07-11","current":-59.084566,"twenty":-43.897892,"median":-35.501693,"eighty":-32.48435,"marketCap":3338745741.38},{"date":"2025-07-18","current":-61.880278,"twenty":-48.308604,"median":-35.791073,"eighty":-32.545465,"marketCap":3494679880.36},{"date":"2025-07-25","current":-58.315576,"twenty":-54.849764,"median":-35.921968,"eighty":-32.616809,"marketCap":3304687864.64},{"date":"2025-08-01","current":-60.559654,"twenty":-57.422661,"median":-36.233253,"eighty":-32.655768,"marketCap":3410643633.03},{"date":"2025-08-08","current":-69.260076,"twenty":-59.023969,"median":-36.597865,"eighty":-32.679287,"marketCap":3910472388.03},{"date":"2025-08-15","current":-72.346957,"twenty":-59.602544,"median":-37.391167,"eighty":-32.709995,"marketCap":4086922647.44},{"date":"2025-08-22","current":-26.724459,"twenty":-60.097702,"median":-37.493155,"eighty":-32.679287,"marketCap":4314209810.62},{"date":"2025-08-29","current":-24.396919,"twenty":-59.865528,"median":-36.699167,"eighty":-32.48435,"marketCap":3966417985.85},{"date":"2025-09-05","current":-22.946281,"twenty":-59.664109,"median":-36.382297,"eighty":-31.979778,"marketCap":3724203040.4},{"date":"2025-09-12","current":-22.941741,"twenty":-59.475774,"median":-35.943012,"eighty":-31.122625,"marketCap":3735810338.07},{"date":"2025-09-19","current":-21.785524,"twenty":-59.316014,"median":-35.857966,"eighty":-29.943039,"marketCap":3550375801.58},{"date":"2025-09-26","current":-21.102028,"twenty":-59.062646,"median":-35.66937,"eighty":-29.751262,"marketCap":3428719452.06},{"date":"2025-10-03","current":-22.266298,"twenty":-59.025902,"median":-35.30284,"eighty":-28.699054,"marketCap":3625414266.5},{"date":"2025-10-10","current":-21.050291,"twenty":-58.738293,"median":-35.189473,"eighty":-26.732175,"marketCap":3423480133.18},{"date":"2025-10-17","current":-19.80269,"twenty":-58.191808,"median":-34.731922,"eighty":-24.468638,"marketCap":3221889328.22},{"date":"2025-10-24","current":-19.801335,"twenty":-57.904825,"median":-34.477812,"eighty":-23.569995,"marketCap":3222890223.42},{"date":"2025-10-31","current":-19.321494,"twenty":-57.532716,"median":-34.141844,"eighty":-22.943557,"marketCap":3150231208.59},{"date":"2025-11-07","current":-18.112503,"twenty":-56.69325,"median":-33.992043,"eighty":-22.558349,"marketCap":2949090425.48},{"date":"2025-11-14","current":-19.583345,"twenty":-55.920234,"median":-33.485756,"eighty":-22.342071,"marketCap":3199584585.23}],"updateTime":1763449919575},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AAPG\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2560111952","title":"每日卖空追踪 | 亚盛医药-B 08月19日卖空量成交10.09万股,卖空比例为2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560111952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560111952?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 16:30","pubTimestamp":1755592237,"startTime":"0","endTime":"0","summary":"亚盛医药-B北京时间08月19日,跌0.72%,卖空量成交10.09万股%,较上一交易日减少71.15%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819172833a491863e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819172833a491863e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAPG"],"gpt_icon":0},{"id":"2560649811","title":"亚盛医药-B08月19日遭主力抛售1755.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560649811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560649811?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 16:15","pubTimestamp":1755591338,"startTime":"0","endTime":"0","summary":"08月19日, 亚盛医药-B股价跌0.72%,报收90.05元,成交金额3.7亿元,换手率1.11%,振幅4.47%,量比1.05。亚盛医药-B今日主力资金净流出1755.3万元,上一交易日主力净流出1042.0万元。该股近5个交易日上涨15.64%,主力资金累计净流入239.1万元;近20日主力资金累计净流出2969.7万元,其中净流出天数为12日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819165914a6eec07d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819165914a6eec07d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAPG"],"gpt_icon":0},{"id":"2560573180","title":"每日卖空追踪 | 亚盛医药-B 08月18日卖空量成交28.74万股,卖空比例为3.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560573180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560573180?lang=zh_cn&edition=fundamental","pubTime":"2025-08-18 16:30","pubTimestamp":1755505835,"startTime":"0","endTime":"0","summary":"亚盛医药-B北京时间08月18日,涨5.34%,卖空量成交28.74万股%,较上一交易日增加63.85%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818174640a48f5efc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818174640a48f5efc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2560263975","title":"冲击四连涨!港股创新药精选ETF(520690)净值创上市新高,资金净流入额6268万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560263975","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560263975?lang=zh_cn&edition=fundamental","pubTime":"2025-08-18 10:21","pubTimestamp":1755483701,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","BK0012","BK0183","HSTECH","BK1593","BK0276","BK1588","BK1589","LU1969619763.USD","BK1191","BK4614","LU2488822045.USD","BK4526","BK4550","YANG","01801","159982","HSCEI","159992","BK0028","AAPG","BK1574","FDN","BK0201","BK1161","BK0188","BK1583","01530","BK4139","ZLAB","BK4548","03933","399300","BK4531","BK4585","LU2328871848.SGD","07226","600109","06978","09688"],"gpt_icon":0},{"id":"2560097525","title":"“港股科技双雄”同步走强!港股通创新药ETF(520880)涨逾2%,亚盛医药飙升9%创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2560097525","media":"新浪基金","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560097525?lang=zh_cn&edition=fundamental","pubTime":"2025-08-18 10:10","pubTimestamp":1755483000,"startTime":"0","endTime":"0","summary":"8月18日,港股早盘高开,港股科技双雄——科网、创新药再度携手走强,截至发稿,创新药新势力——港股通创新药ETF场内价格涨逾2%;重仓港股互联网龙头的港股互联网ETF场内价格现涨1.54%。 亚盛医药-B一度上探9%,创历史新高,消息面上,公司自主研发的利生妥治疗中高危MDS III期临床研究获美国FDA和欧洲EMA批准。此外,权重股集体走强,三生制药涨近5%,信达生物涨超4%,再鼎医药涨超3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/2025-08-18/doc-infmkiwn2326153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HSTECH","515120","BK4139","159741","HSCEI","AAPG","YANG","BK4614"],"gpt_icon":1},{"id":"2560730829","title":"港股异动 | 亚盛医药-B(06855)高开逾4% 利生妥治疗中高危MDS III期临床研究获美国FDA和欧洲EMA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2560730829","media":"智通财经","labels":["policyRegulatory","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560730829?lang=zh_cn&edition=fundamental","pubTime":"2025-08-18 09:24","pubTimestamp":1755480288,"startTime":"0","endTime":"0","summary":"据悉,利生妥是亚盛医药自主研发的新型口服Bcl-2选择性抑制剂,通过选择性抑制 Bcl-2蛋白,恢复癌细胞的正常凋亡过程,从而达到治疗肿瘤的目的。利生妥为中国首个获批上市的国产原创Bcl-2抑制剂。截止本公告日期,利生妥也是国际上唯一正推进中高危MDS注册III期临床的Bcl-2抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","BK4081","BK1161","AAPG","III","BK4139","06855","BK1574","EMA"],"gpt_icon":0},{"id":"2560350973","title":"部分中概股夜盘上扬爱奇艺、亚盛医药涨近5%小牛电动涨超4%哔哩哔哩涨超2%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2560350973","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560350973?lang=zh_cn&edition=fundamental","pubTime":"2025-08-18 08:54","pubTimestamp":1755478479,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BILI","BK1608","LU0307460666.USD","LU0359201612.USD","SG9999001093.SGD","LU0163747925.USD","BK4566","LU0630378692.HKD","BK4563","LU2097828714.EUR","LU2097828557.USD","09626","BK4091","BK1618","BK4085","BK1104","09888","LU0708995583.HKD","LU0588546209.SGD","SG9999006597.SGD","LU1048588211.SGD","LU0229945570.USD","BK1587","BK1588","BK4108","IE0034224299.USD","BK4526","LU0072462343.USD","LU2097828631.EUR","BK4588","BK4504","HK0000306685.HKD","BK4585","NIU","LU0856984785.SGD","LU0821914370.USD","LU0417516738.SGD","SG9999014674.SGD","BK4503","BIDU","LU0348825331.USD","BK4554","SG9999002828.SGD","89888","AAPG","TTTN","LU0456827905.SGD","LU0197773160.USD","LU2476274308.USD","IQ"],"gpt_icon":0},{"id":"2560978538","title":"亚盛医药-B(06855):利生妥®一线治疗中高危MDS患者的全球注册III期临床研究获美国FDA和欧洲EMA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2560978538","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560978538?lang=zh_cn&edition=fundamental","pubTime":"2025-08-18 07:34","pubTimestamp":1755473685,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亚盛医药-B 发布公告,公司自主研发的Bcl-2选择性抑制剂利沙托克拉联合阿扎胞苷一线治疗新诊断的中高危骨髓增生异常综合症患者的全球注册III期临床研究获美国食品药品监督管理局和欧洲药品管理局同意开展。截止本公告日期,利生妥也是国际上唯一正推进中高危MDS注册III期临床的Bcl-2抑制剂。利生妥为中国首个获批上市的国产原创Bcl-2抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330627.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4081","EMA","06855","BK4134","AAPG","III","BK4139","BK1161","BK1574"],"gpt_icon":0},{"id":"2559834599","title":"亚盛医药-B08月13日获主力加仓1320.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559834599","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559834599?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 16:15","pubTimestamp":1755072937,"startTime":"0","endTime":"0","summary":"08月13日, 亚盛医药-B股价涨3.45%,报收81.00元,成交金额2.4亿元,换手率0.81%,振幅4.28%,量比0.60。亚盛医药-B今日主力资金净流入1320.6万元,上一交易日主力净流入1520.2万元。该股近5个交易日下跌3.11%,主力资金累计净流出1928.6万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出5246.8万元,其中净流出天数为12日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813170129a485ff36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813170129a485ff36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2558691272","title":"亚盛医药8月11日成交额为9.30万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558691272","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558691272?lang=zh_cn&edition=fundamental","pubTime":"2025-08-12 09:15","pubTimestamp":1754961314,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日,亚盛医药成交额为9.30万美元,成交额较昨日减少64.22%,当日成交量为2326.00股。亚盛医药于2025年8月11日跌4.55%,报40.04美元,该股过去5个交易日涨6.49%,年初至今涨132.12%,过去60日涨71.11%。公司专注于开发抑制蛋白质相互作用以恢复细胞凋亡或程序性细胞死亡的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091521a482e0f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091521a482e0f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAPG"],"gpt_icon":0},{"id":"2557957884","title":"亚盛医药-B:董事会会议通告","url":"https://stock-news.laohu8.com/highlight/detail?id=2557957884","media":"香港交易所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557957884?lang=zh_cn&edition=fundamental","pubTime":"2025-08-08 21:41","pubTimestamp":1754660495,"startTime":"0","endTime":"0","summary":"亚盛医药集团宣布,将于2025年8月20日(星期三)召开董事会会议,主要议程为审议及批准集团截至2025年6月30日止六个月之未经审核中期业绩,并讨论相关业绩发布事宜。本次会议由董事会主席兼执行董事杨大俊博士主持,董事会成员包括非执行董事王少萌博士、吕大忠博士,以及独立非执行董事叶长青先生、任为先生、David Sidransky博士、Marina S. Bozilenko女士、Debra Yu博士及Marc E. Lippman, MD。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808220437a6db2d80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808220437a6db2d80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1161","BK1574","AAPG"],"gpt_icon":0},{"id":"2558043925","title":"小摩:升亚盛医药目标价至93港元 评级“增持”","url":"https://stock-news.laohu8.com/highlight/detail?id=2558043925","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558043925?lang=zh_cn&edition=fundamental","pubTime":"2025-08-08 15:33","pubTimestamp":1754638380,"startTime":"0","endTime":"0","summary":" 摩根大通发布研报称,亚盛医药股价年内累涨约83%,与恒生医疗保健指数的强劲表现同步。该行在最近举行的中美生物技术论坛与管理层讨论后,并考虑公司产品管线的最新进展,小摩更新了模型。小摩纳入对产品更乐观的销售预估,将亚盛医药目标价由原先52港元大幅上调79%至93港元;维持增持评级。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2025-08-08/doc-infkhfmz5145209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AAPG"],"gpt_icon":0},{"id":"2557488255","title":"小摩:升亚盛医药(06855.HK)目标价至93港元 评级“增持”","url":"https://stock-news.laohu8.com/highlight/detail?id=2557488255","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557488255?lang=zh_cn&edition=fundamental","pubTime":"2025-08-08 14:13","pubTimestamp":1754633621,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2456880835.USD","LU0203347892.USD","LU1670628061.USD","LU2462157665.USD","SG9999002232.USD","LU0496365809.HKD","LU1551013425.SGD","LU0976567544.SGD","06855","LU2746668974.SGD","LU2505996681.GBP","LU1244550577.SGD","LU0251132253.USD","LU0211331839.USD","IE00BLSP4452.SGD","BK1161","LU2756315664.SGD","LU1032466523.USD","IE00B3S45H60.SGD","IE00BLSP4239.USD","LU0211326839.USD","LU0971096721.USD","LU2237443382.USD","LU0215105999.USD","LU0787776722.HKD","LU0320765489.SGD","159506","LU1917777945.USD","LU2756315318.SGD","LU2237443895.HKD","LU1720051108.HKD","LU1670627923.USD","LU1668664300.SGD","LU1551013342.USD","LU2023250843.SGD","IE0034235188.USD","LU0048584097.USD","LU0345769631.USD","BK4504","AAPG","BK4581","LU1914381329.SGD","IE000M9KFDE8.USD","LU1974910355.USD","LU0820561909.HKD","LU0417517546.SGD","SG9999002224.SGD","IE00BZ1G4Q59.USD","LU1894683348.USD","LU0234572021.USD"],"gpt_icon":0},{"id":"2557184755","title":"亚盛医药8月7日成交额为13.12万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557184755","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557184755?lang=zh_cn&edition=fundamental","pubTime":"2025-08-08 09:15","pubTimestamp":1754615715,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日,亚盛医药成交额为13.12万美元,成交额较昨日减少80.34%,当日成交量为3054.00股。亚盛医药于2025年8月7日涨0.3%,报42.81美元,该股过去5个交易日涨15.7%,年初至今涨148.17%,过去60日涨76.9%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-08-07|13.12万|-80.34%|3054.00|#|2025-08-06|66.76万|-13.27%|1.56万|#|2025-08-05|76.97万|610.80%|1.82万|#|2025-08-04|10.83万|-69.86%|2890.00|#|2025-08-01|35.92万|236.22%|9770.00|亚盛医药集团是一家临床阶段的生物技术公司,从事癌症、乙型肝炎病毒和某些年龄相关疾病的新型小规模疗法的开发和销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808091527a47bfa2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808091527a47bfa2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAPG"],"gpt_icon":0},{"id":"2557095153","title":"亚盛医药上涨2.38%,报43.0美元/股,总市值39.97亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557095153","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557095153?lang=zh_cn&edition=fundamental","pubTime":"2025-08-07 01:04","pubTimestamp":1754499858,"startTime":"0","endTime":"0","summary":"8月7日,亚盛医药盘中上涨2.38%,截至01:04,报43.0美元/股,成交57.98万美元,总市值39.97亿美元。财务数据显示,截至2024年12月31日,亚盛医药收入总额9.81亿人民币,同比增长341.77%;归母净利润-4.05亿人民币,同比增长56.2%。目前公司正在中国、美国、澳大利亚及欧洲开展40多项临床试验。截至目前,公司共有4个在研新药获得16项FDA和1项欧盟孤儿药资格认定,2项FDA快速通道资格以及2项FDA儿童罕见病资格认证。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/07010452260174.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2557358048","title":"亚盛医药8月4日成交额为10.83万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557358048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557358048?lang=zh_cn&edition=fundamental","pubTime":"2025-08-05 09:15","pubTimestamp":1754356515,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日,亚盛医药成交额为10.83万美元,成交额较昨日减少69.86%,当日成交量为2890.00股。亚盛医药于2025年8月4日涨1.08%,报37.6美元,该股过去5个交易日跌4.25%,年初至今涨117.97%,过去60日涨55.56%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-08-04|10.83万|-69.86%|2890.00|#|2025-08-01|35.92万|236.22%|9770.00|#|2025-07-31|10.68万|-63.12%|2893.00|#|2025-07-30|28.97万|49.26%|7639.00|#|2025-07-29|19.41万|-50.35%|4877.00|亚盛医药集团是一家临床阶段的生物技术公司,从事癌症、乙型肝炎病毒和某些年龄相关疾病的新型小规模疗法的开发和销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805091530a6d35278&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805091530a6d35278&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2556844453","title":"亚盛医药8月1日成交额为35.92万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556844453","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556844453?lang=zh_cn&edition=fundamental","pubTime":"2025-08-02 09:15","pubTimestamp":1754097315,"startTime":"0","endTime":"0","summary":"美东时间2025年8月1日,亚盛医药成交额为35.92万美元,成交额较昨日增加236.22%,当日成交量为9770.00股。亚盛医药于2025年8月1日涨0.54%,报37.2美元,该股过去5个交易日跌1.59%,年初至今涨115.65%,过去60日涨44.19%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-08-01|35.92万|236.22%|9770.00|#|2025-07-31|10.68万|-63.12%|2893.00|#|2025-07-30|28.97万|49.26%|7639.00|#|2025-07-29|19.41万|-50.35%|4877.00|#|2025-07-28|39.09万|211.84%|9883.00|亚盛医药集团是一家临床阶段的生物技术公司,从事癌症、乙型肝炎病毒和某些年龄相关疾病的新型小规模疗法的开发和销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802091529a470959a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802091529a470959a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAPG"],"gpt_icon":0},{"id":"2555107634","title":"亚盛医药7月30日成交额为28.97万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555107634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555107634?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 09:15","pubTimestamp":1753924515,"startTime":"0","endTime":"0","summary":"美东时间2025年7月30日,亚盛医药成交额为28.97万美元,成交额较昨日增加49.26%,当日成交量为7639.00股。亚盛医药于2025年7月30日跌6.44%,报37.5美元,该股过去5个交易日跌2.11%,年初至今涨117.39%,过去60日涨47.17%。公司专注于开发抑制蛋白质相互作用以恢复细胞凋亡或程序性细胞死亡的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731091523a6ca7dab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731091523a6ca7dab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2555069153","title":"亚盛医药上涨2.29%,报40.168美元/股,总市值37.34亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555069153","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555069153?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 03:59","pubTimestamp":1753819150,"startTime":"0","endTime":"0","summary":"7月30日,亚盛医药盘中上涨2.29%,截至03:59,报40.168美元/股,成交18.09万美元,总市值37.34亿美元。财务数据显示,截至2024年12月31日,亚盛医药收入总额9.81亿人民币,同比增长341.77%;归母净利润-4.05亿人民币,同比增长56.2%。目前公司正在中国、美国、澳大利亚及欧洲开展40多项临床试验。截至目前,公司共有4个在研新药获得16项FDA和1项欧盟孤儿药资格认定,2项FDA快速通道资格以及2项FDA儿童罕见病资格认证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073004044194c2374a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073004044194c2374a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139","ASPHF"],"gpt_icon":0},{"id":"2555039721","title":"国内首款Bcl-2抑制剂利生妥®在京东健康全网首发 助力血液肿瘤精准治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2555039721","media":"砍柴网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555039721?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 00:00","pubTimestamp":1753718400,"startTime":"0","endTime":"0","summary":"近日,亚盛医药自主研发的新型口服Bcl-2选择性抑制剂——利生妥在京东健康全网独家首发。通过选择性抑制Bcl-2蛋白,恢复肿瘤细胞的正常凋亡过程,可达到治疗肿瘤的目的。在此之前,中国尚未有Bcl-2抑制剂获批用于CLL/SLL的治疗。今年7月,利生妥正式在国内上市后,选择在京东健康线上首发,正是看重线上渠道能实现药品更广泛可及的优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072916471394c129b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072916471394c129b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["86618","PPI","BK4570","AAPG","06855","06618","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":123,"code":"91000000","status":"200"}]}}